Literature DB >> 16287236

Cell transduction pathways of transportans.

Kärt Padari1, Pille Säälik, Mats Hansen, Kaida Koppel, Raivo Raid, Ulo Langel, Margus Pooga.   

Abstract

Attempts to unravel the cell translocation mechanism of a growing number of cell-penetrating peptides (CPP) have revealed molecular determinants essential for internalization ability. The peptide sequence and the charge have been proposed to be the major factors in determining the membrane interaction mode and subsequent internalization pathway. Recent research in this field has shifted to search and design of novel CPPs with predefined vectorial properties and elucidation of the mechanism of cell entry of CPPs with high cargo delivery efficiency. Here we present a map of interaction modes with cell surface and intracellular traffic of transportan and its analogue TP10 complexed with fluorescently labeled avidin or streptavidin-gold conjugates. The protein cargo complexed with either peptide is transduced into HeLa and Bowes cells mostly in the endocytic vesicles with heterogeneous morphology and size as demonstrated by transmission electron microscopy (TEM) and confocal laser scanning fluorescence microscopy. Most of the induced vesicles are large, with 0.5-2 mum diameter, probably macropinosomes, but the complexes are present also in smaller vesicles, suggesting involvement of different pathways. Later the majority of complexes are translocated from the cell periphery into vesicles of perinuclear region and partly to lysosomes. A fraction of transportan-streptavidin complexes is present also freely in cytoplasm, both in the close vicinity of plasma membrane and more centrally, suggesting the escape from endosomal vesicles, since vesicles with discontinuous membrane were also detected by TEM. The cell-translocation process of transportan-protein complexes is temperature dependent and strongly inhibited at 8-10 degrees C and blocked at 4 degrees C when only interaction with the plasma membrane takes place.

Mesh:

Substances:

Year:  2005        PMID: 16287236     DOI: 10.1021/bc050125z

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  21 in total

1.  Cell-penetrating peptides split into two groups based on modulation of intracellular calcium concentration.

Authors:  Annely Lorents; Praveen Kumar Kodavali; Nikita Oskolkov; Ülo Langel; Mattias Hällbrink; Margus Pooga
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

Review 2.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

3.  Cell-penetrating peptide secures an efficient endosomal escape of an intact cargo upon a brief photo-induction.

Authors:  Helin Räägel; Margot Hein; Asko Kriiska; Pille Säälik; Anders Florén; Ülo Langel; Margus Pooga
Journal:  Cell Mol Life Sci       Date:  2013-07-13       Impact factor: 9.261

4.  Cellular uptake of gold nanoparticles directly cross-linked with carrier peptides by osteosarcoma cells.

Authors:  Deendayal Mandal; Avudaippan Maran; Michael J Yaszemski; Mark E Bolander; Gobinda Sarkar
Journal:  J Mater Sci Mater Med       Date:  2008-09-21       Impact factor: 3.896

5.  Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei.

Authors:  Romanico B G Arrighi; Charles Ebikeme; Yang Jiang; Lisa Ranford-Cartwright; Michael P Barrett; Ulo Langel; Ingrid Faye
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

6.  Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: role of endocytosis and treatment implications.

Authors:  Jingsong Zhu; Paul W Luther; Qixin Leng; A James Mixson
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 7.  Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.

Authors:  Yinghuan Li; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  Adv Drug Deliv Rev       Date:  2011-05-03       Impact factor: 15.470

8.  Autonomous translocation and intracellular trafficking of the cell-penetrating and immune-suppressive effector protein YopM.

Authors:  Julia Scharnert; Lilo Greune; Dagmar Zeuschner; Marie-Luise Lubos; M Alexander Schmidt; Christian Rüter
Journal:  Cell Mol Life Sci       Date:  2013-07-09       Impact factor: 9.261

9.  Role of Membrane Potential on Entry of Cell-Penetrating Peptide Transportan 10 into Single Vesicles.

Authors:  Md Mizanur Rahman Moghal; Md Zahidul Islam; Farzana Hossain; Samiron Kumar Saha; Masahito Yamazaki
Journal:  Biophys J       Date:  2019-11-20       Impact factor: 4.033

10.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.